How These Therapies Are Given: IV, Injection, and Intrathecal

How a therapy is delivered is not a technicality. The route determines where the signals concentrate, and it should follow from the problem being addressed.

One of the most practical questions a patient has is also one of the least explained: how, exactly, are these therapies delivered, and what does each method actually accomplish? The route is not an afterthought. It is a deliberate clinical decision, matched to what we are trying to achieve. There are three main routes, and there is good reason we often combine them. Intravenous (IV) delivery, and what it does. Here the cells and their signals are introduced into a vein and enter the circulation, traveling throughout the body. IV is the route of choice when the goal is systemic — body-wide. Because so much of what regenerative medicine addresses is itself systemic, this matters enormously. Chronic, low-grade inflammation is body- wide. The decline of signaling that comes with aging is body-wide. Immune dysregulation is body-wide. An IV allows the cells' anti-inflammatory and immune- modulating signals to reach many tissues and systems at once, supporting the body's overall internal environment rather than just one spot. This is why IV therapy is so often used for the broad concerns patients bring — general aging and vitality, systemic inflammation, immune balance, recovery, and overall function. It works on the whole system, addressing the kind of widespread, low-grade dysfunction that no single local treatment could reach. There is a fascinating detail worth knowing about IV delivery. When cells first enter the bloodstream, large numbers of them gather in the lungs before traveling onward — something researchers call the pulmonary first-pass effect. It is not a problem to be avoided; many believe it is part of how the therapy works. IN PLAIN TERMS When crews first arrive at a large site, many gather at the entrance before dispersing. Infused cells do something similar, collecting first in the lungs — a phenomenon called the pulmonary first-pass effect. Far from being a flaw, this staging area may be part of how the therapy works, a gathering point from which the cells release their signals into the circulation. Local injection, and what it does. Here the cells are placed directly into the area of concern — a joint, a tendon, a damaged disc, an injured soft tissue. The logic is intuitive and powerful: deliver a high concentration of cells and signals exactly where the problem is. Once there, the secretome goes to work locally — calming inflammation in that joint, recruiting repair cells to that tendon, stimulating new blood supply to that damaged area, supporting the survival of stressed local cells, and encouraging functional repair rather than scar. This is the route of choice for a specific, localized problem such as an arthritic knee or an injured shoulder, where concentrating the full effect in one place is exactly what is needed. IN PLAIN TERMS Think of a joint as a hinge that has lost its lubrication and worn its surfaces. A local injection delivers the repair signals directly to that hinge — addressing the friction and supporting the tissue's own repair, rather than simply masking the grinding from a distance. Intrathecal delivery, and what it does. This is the most specialized route. Rather than entering the bloodstream or a joint, the cells are introduced into the cerebrospinal fluid — the protected fluid surrounding the brain and spinal cord. Its purpose is to reach the central nervous system, which is otherwise one of the hardest regions in the body to access because it is so well shielded. It is more technically demanding and is reserved for situations where the nervous system itself is the target. Why we often combine IV with injection. Here the clinical reasoning becomes clear, and it follows directly from everything this book has said about the body being a connected, communicating whole. A local injection concentrates the effect at a specific problem — the worn knee, the injured tendon. An IV, given alongside it, supports the entire body at the same time — calming systemic inflammation, supporting overall communication, and creating a more favorable internal environment in which that local repair can succeed. IN PLAIN TERMS Imagine renovating one critical room in a house while also restoring the building's overall systems — the power, the plumbing, the climate control. Fixing the room helps, but it works far better when the whole building is functioning well around it. Combining a local injection with an IV applies the same logic to the body: treat the specific problem and support the whole system at once. There is real biological sense to this. A joint does not heal in isolation; it heals within a body whose overall inflammatory state, immune balance, and signaling environment either help or hinder the process. By addressing both at once — the local target and the systemic terrain — the combined approach gives the body its best opportunity to do what it is designed to do. This is why the question of route is not a technicality. It reflects a thoughtful match between how a therapy is delivered and what it is meant to achieve.